N/A
N=44
Use of Transcranial Direct Current Stimulation (tDCS) Coupled With Constraint Induced Movement Therapy in Stroke Patient
Stroke · Healthy
Bottom Line
View on ClinicalTrials.gov: NCT01143649 ↗Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcome: Primary: Jebsen Taylor Hand Function Test — 68; 80 seconds
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- transcranial direct current stimulation (tDCS) (Device); constraint induced movement therapy (CIMT) (Procedure); transcranial alternating current stimulation (tACS) (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Spaulding Rehabilitation Hospital
- Primary completion
- Apr 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Jebsen Taylor Hand Function Test |
68; 80 | — |
| PRIMARY Cortical Excitability |
19.8; 0.8 | — |
| PRIMARY Cortical Oscillations - EEG |
-0.03; 0.07 | — |
Summary
The purpose of this study is to determine whether noninvasive brain stimulation associated with motor learning offers an additional benefit than motor learning alone in patients with stroke.
The investigators hypothesis is that active transcranial direct current stimulation (tDCS) combined with constraint induced movement therapy (CIMT) will induce a greater motor function improvement as compared with sham tDCS combined with CIMT.
Eligibility Criteria
Inclusion Criteria
All subjects must be between the ages of 18-90 and must not be pregnant.
Additional Entry criteria for Stroke subject enrollment:
- First-time clinical ischemic or hemorrhagic cerebrovascular accident - evidenced by a radiological (or physician's) report;
- Weakness, defined as score of less than 55 (out of 66) on arm motor Fugl-Meyer (FM) scale
- Stroke onset >6 months prior to study enrollment.
Exclusion Criteria
- Significant pre-stroke disability;
- Major depression, as defined by Hamilton Depression (HAM-D) scale grater then or equal 17 if needed (history of depression before the stroke);
- Any substantial decrease in alertness, language reception, or attention that might interfere with understanding instructions for motor testing;
- Excessive pain in any joint of the paretic extremity (not applicable to severe stroke subjects);
- Contraindications to single pulse Transcranial Magnetic Stimulation (TMS) (TMS will be used to measure cortical excitability) such as metal head implants
- history of seizures
- unexplained loss of consciousness
- metal in the head
- frequent or severe headaches or neck pain
- implanted brain medical devices.
- Contraindications to tDCS
- metal in the head
- implanted brain medical devices
- Advanced liver, kidney, cardiac, or pulmonary disease;
- A terminal medical diagnosis consistent with survival < 1 year;
- Coexistent major neurological or psychiatric disease as to decrease number of confounders;
- A history of significant alcohol or drug abuse in the prior 6 months;
- Use of carbamazepine and amitriptyline;
- Subjects may not be actively enrolled in a separate intervention study targeting stroke recovery and
- Subjects may not have already received constraint induced motor therapy and/or tDCS treatment for stroke;
- History of epilepsy before stroke (or episodes of seizures within the last six months).
- Subjects with global aphasia and deficits of comprehension
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT01143649). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.